Anavex Life Sciences Corp (AVXL)

[bas2020]

Noticed the below session at the myBIO conference...

Seems AVXL was an early adopter of the Adaptive Clinical Trial, which was guided by the FDA.


Revolutionizing Clinical Trials for Alzheimer’s: An International Perspective on Adaptive Clinical Trials

Dementia affects 47 million people globally, devastating lives and placing a huge burden on families, carers and society. Despite decades of research, there is still neither treatment nor cure for Alzheimer’s disease and success in clinical trials remains elusive. Pioneering projects on both sides of the Atlantic are working together to turn this situation around by running adaptive clinical trials – a first in Alzheimer’s research. In adaptive trials, multiple treatments are tested at the same time and the results analyzed continuously. This allows a faster assessment of treatments and the identification of groups of patients that respond best to them. In this session, leading dementia experts will share their experiences and trigger debate on how best to overcome the challenges to delivering successful clinical trials for much-needed Alzheimer’s treatments.